Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cancer Specialists Seek Fewer Restrictions On Medicare Coverage For PET

This article was originally published in The Gray Sheet

Executive Summary

Oncologists and imaging device manufacturers are urging CMS not to restrict coverage for PET scans used to detect recurrence, monitor treatment or restage a cancer prognosis after its initial diagnosis

You may also be interested in...



Oncology PET Scan Coverage Expands As CMS Lifts Some Data Mandates

Medicare coverage of PET scans for oncology indications will be less restrictive under a national coverage determination finalized April 3

Oncology PET Scan Coverage Expands As CMS Lifts Some Data Mandates

Medicare coverage of PET scans for oncology indications will be less restrictive under a national coverage determination finalized April 3

CMS Proposes To Require Less Data Collection For Cancer PET Coverage

CMS plans to remove some of its coverage-with-evidence-development (CED) requirements for positron emission tomography scans for an array of cancer types

Related Content

Topics

UsernamePublicRestriction

Register

MT027070

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel